These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

542 related items for PubMed ID: 19701106

  • 1. Prognostic value of 18F-FDG uptake on positron emission tomography in patients with pathologic stage I non-small cell lung cancer.
    Um SW, Kim H, Koh WJ, Suh GY, Chung MP, Kwon OJ, Choi JY, Han J, Lee KS, Kim J.
    J Thorac Oncol; 2009 Nov; 4(11):1331-6. PubMed ID: 19701106
    [Abstract] [Full Text] [Related]

  • 2. Prognostic value of SUVmax and metabolic tumor volume on 18F-FDG PET/CT in early stage non-small cell lung cancer patients without LN metastasis.
    Yoo IeR, Chung SK, Park HL, Choi WH, Kim YK, Lee KY, Wang YP.
    Biomed Mater Eng; 2014 Nov; 24(6):3091-103. PubMed ID: 25227018
    [Abstract] [Full Text] [Related]

  • 3. Association between 18F-fluoro-2-deoxy-D-glucose uptake values and tumor vitality: prognostic value of positron emission tomography in early-stage non-small cell lung cancer.
    Dooms C, van Baardwijk A, Verbeken E, van Suylen RJ, Stroobants S, De Ruysscher D, Vansteenkiste J.
    J Thorac Oncol; 2009 Jul; 4(7):822-8. PubMed ID: 19487964
    [Abstract] [Full Text] [Related]

  • 4. Prognostic value of FDG uptake in early stage non-small cell lung cancer.
    Hanin FX, Lonneux M, Cornet J, Noirhomme P, Coulon C, Distexhe J, Poncelet AJ.
    Eur J Cardiothorac Surg; 2008 May; 33(5):819-23. PubMed ID: 18374589
    [Abstract] [Full Text] [Related]

  • 5. The variation of prognostic significance of Maximum Standardized Uptake Value of [18F]-fluoro-2-deoxy-glucose positron emission tomography in different histological subtypes and pathological stages of surgically resected Non-Small Cell Lung Carcinoma.
    Casali C, Cucca M, Rossi G, Barbieri F, Iacuzio L, Bagni B, Uliano M.
    Lung Cancer; 2010 Aug; 69(2):187-93. PubMed ID: 19942313
    [Abstract] [Full Text] [Related]

  • 6. Measurement of tumor volume by PET to evaluate prognosis in patients with advanced non-small cell lung cancer treated by non-surgical therapy.
    Yan H, Wang R, Zhao F, Zhu K, Jiang S, Zhao W, Feng R.
    Acta Radiol; 2011 Jul 01; 52(6):646-50. PubMed ID: 21508201
    [Abstract] [Full Text] [Related]

  • 7. Pretreatment [18F]-fluoro-2-deoxy-glucose positron emission tomography maximum standardized uptake value as predictor of distant metastasis in early-stage non-small cell lung cancer treated with definitive radiation therapy: rethinking the role of positron emission tomography in personalizing treatment based on risk status.
    Nair VJ, MacRae R, Sirisegaram A, Pantarotto JR.
    Int J Radiat Oncol Biol Phys; 2014 Feb 01; 88(2):312-8. PubMed ID: 24411602
    [Abstract] [Full Text] [Related]

  • 8. FDG Uptake on Positron Emission Tomography Correlates with Survival and Time to Recurrence in Patients with Stage I Non-Small-Cell Lung Cancer.
    Kwon W, Howard BA, Herndon JE, Patz EF.
    J Thorac Oncol; 2015 Jun 01; 10(6):897-902. PubMed ID: 25811445
    [Abstract] [Full Text] [Related]

  • 9. Use of maximum standardized uptake value on fluorodeoxyglucose positron-emission tomography in predicting lymph node involvement in patients with primary non-small cell lung cancer.
    Muto J, Hida Y, Kaga K, Ohtaka K, Okamoto S, Tamaki N, Nakada-Kubota R, Hirano S, Matsui Y.
    Anticancer Res; 2014 Feb 01; 34(2):805-10. PubMed ID: 24511016
    [Abstract] [Full Text] [Related]

  • 10. Pretreatment maximum standardized uptake value on 18F-fluorodeoxyglucose positron emission tomography is a predictor of outcome for stage I non-small cell lung cancer after stereotactic body radiotherapy.
    Tanaka H, Hayashi S, Hoshi H.
    Asia Pac J Clin Oncol; 2016 Mar 01; 12(1):e113-7. PubMed ID: 24176011
    [Abstract] [Full Text] [Related]

  • 11. Volume-based parameters of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography improve outcome prediction in early-stage non-small cell lung cancer after surgical resection.
    Hyun SH, Choi JY, Kim K, Kim J, Shim YM, Um SW, Kim H, Lee KH, Kim BT.
    Ann Surg; 2013 Feb 01; 257(2):364-70. PubMed ID: 22968069
    [Abstract] [Full Text] [Related]

  • 12. Difference in prognostic values of maximal standardized uptake value on fluorodeoxyglucose-positron emission tomography and cyclooxygenase-2 expression between lung adenocarcinoma and squamous cell carcinoma.
    Shimizu K, Maeda A, Yukawa T, Nojima Y, Saisho S, Okita R, Nakata M.
    World J Surg Oncol; 2014 Nov 13; 12():343. PubMed ID: 25392182
    [Abstract] [Full Text] [Related]

  • 13. Standardized Uptake Values in the Primary Lesions of Non-Small-Cell Lung Cancer in FDG-PET/CT Can Predict Regional Lymph Node Metastases.
    Nakamura H, Saji H, Marushima H, Kimura H, Tagaya R, Kurimoto N, Hoshikawa M, Takagi M.
    Ann Surg Oncol; 2015 Dec 13; 22 Suppl 3():S1388-93. PubMed ID: 25900205
    [Abstract] [Full Text] [Related]

  • 14. The maximum standardized uptake value of fluorodeoxyglucose positron emission tomography of the primary tumour is a good predictor of pathological nodal involvement in clinical N0 non-small-cell lung cancer.
    Miyasaka Y, Suzuki K, Takamochi K, Matsunaga T, Oh S.
    Eur J Cardiothorac Surg; 2013 Jul 13; 44(1):83-7. PubMed ID: 23233074
    [Abstract] [Full Text] [Related]

  • 15. Influence of Body Mass Index on the Prognostic Value of Tumor ¹⁸F-FDG Uptake in Stage I Non-Small Cell Lung Cancer.
    Hyun SH, Lee KH, Choi JY, Kim BT, Kim J, Zo JI, Kim H, Kwon OJ, Ahn HK.
    PLoS One; 2015 Jul 13; 10(12):e0145020. PubMed ID: 26684001
    [Abstract] [Full Text] [Related]

  • 16. Predictive value of primary fluorine-18 fluorodeoxyglucose standard uptake value for a better choice of systematic nodal dissection or sampling in clinical stage ia non--small-cell lung cancer.
    Li X, Zhang H, Xing L, Xu X, Xie P, Ma H, Zhang L, Chen M, Sun X, Xu W, Chen L, Yu J.
    Clin Lung Cancer; 2013 Sep 13; 14(5):568-73. PubMed ID: 23835164
    [Abstract] [Full Text] [Related]

  • 17. 18F-FDG uptake as a biologic prognostic factor for recurrence in patients with surgically resected non-small cell lung cancer.
    Higashi K, Ueda Y, Arisaka Y, Sakuma T, Nambu Y, Oguchi M, Seki H, Taki S, Tonami H, Yamamoto I.
    J Nucl Med; 2002 Jan 13; 43(1):39-45. PubMed ID: 11801701
    [Abstract] [Full Text] [Related]

  • 18. Predictive significance of standardized uptake value parameters of FDG-PET in patients with non-small cell lung carcinoma.
    Duan XY, Wang W, Li M, Li Y, Guo YM.
    Braz J Med Biol Res; 2015 Mar 13; 48(3):267-72. PubMed ID: 25651460
    [Abstract] [Full Text] [Related]

  • 19. Fluorine-18 fluorodeoxyglucose positron emission tomographic maximal standardized uptake value predicts survival independent of clinical but not pathologic TNM staging of resected non-small cell lung cancer.
    Downey RJ, Akhurst T, Gonen M, Park B, Rusch V.
    J Thorac Cardiovasc Surg; 2007 Jun 13; 133(6):1419-27. PubMed ID: 17532932
    [Abstract] [Full Text] [Related]

  • 20. Prognostic value of preoperative positron emission tomography in resected stage I non-small cell lung cancer.
    Goodgame B, Pillot GA, Yang Z, Shriki J, Meyers BF, Zoole J, Gao F, Dehdashti F, Patterson A, Siegel BA, Govindan R.
    J Thorac Oncol; 2008 Feb 13; 3(2):130-4. PubMed ID: 18303432
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.